Reversible Edema in the Penumbra Correlates With Severity of Hypoperfusion

Author:

Scheldeman Lauranne123ORCID,Wouters Anke123ORCID,Dupont Patrick45ORCID,Christensen Soren6,Boutitie Florent78,Cheng Bastian9ORCID,Ebinger Martin1011,Endres Matthias1012131415ORCID,Fiebach Jochen B.10ORCID,Gerloff Christian9,Muir Keith W.16ORCID,Nighoghossian Norbert17ORCID,Pedraza Salvador18ORCID,Simonsen Claus Z.19ORCID,Ringelstein Erich B.20,Chamorro Angel21ORCID,Grond Martin2223,Laage Rico24,Schneider Armin25,Thomalla Götz9ORCID,Thijs Vincent2627ORCID,Lemmens Robin123ORCID

Affiliation:

1. Department of Neurology, University Hospitals Leuven, Belgium (L.S., A.W., R. Lemmens).

2. Department of Neurosciences, Experimental Neurology (L.S., A.W., R. Lemmens), KU Leuven–University of Leuven, Belgium.

3. Center for Brain and Disease Research, Laboratory of Neurobiology, Vlaams Instituut voor Biotechnologie (VIB), Leuven, Belgium (L.S., A.W., R. Lemmens).

4. Department of Neurosciences, Laboratory for Cognitive Neurology (P.D.), KU Leuven–University of Leuven, Belgium.

5. Leuven Brain Institute, Belgium (P.D.).

6. GrayNumber Analytics, Lomma, Sweden (S.C.).

7. Hospices Civils de Lyon, Service de Biostatistique, France (F.B.).

8. Université Lyon 1, Villeurbanne, France (F.B.).

9. Klinik und Poliklinik für Neurologie, Kopf- und Neurozentrum, University Medical Center Hamburg-Eppendorf, Germany (B.C., C.G., G.T.).

10. Center for Stroke Research Berlin (M. Ebinger, M. Endres, J.B.F.), Charité–Universitätsmedizin Berlin, Germany.

11. Klinik für Neurologie, Medical Park Berlin Humboldtmühle, Germany (M. Ebinger).

12. Klinik und Hochschulambulanz für Neurologie (M. Endres), Charité–Universitätsmedizin Berlin, Germany.

13. German Center for Cardiovascular Research, Partner Site Berlin (M. Endres).

14. German Center for Neurodegenerative Diseases, Partner Site Berlin (M. Endres).

15. ExcellenceCluster “NeuroCure” (M. Endres).

16. Institute of Neuroscience and Psychology, University of Glasgow, United Kingdom (K.W.M.).

17. Department of Stroke Medicine, Université Claude Bernard Lyon 1, CREATIS CNRS UMR 5220-INSERM U1206, Hospices Civils de Lyon, France (N.N.).

18. Department of Radiology, Institut de Diagnostic per la Image, Hospital Dr Josep Trueta, Institut d’Investigació Biomedica de Girona, Parc Hospitalari Marti i Julia de Salt–Edifici M2, Spain (S.P.).

19. Department of Neurology, Aarhus University Hospital, Denmark (C.Z.S.).

20. Department of Neurology, University of Münster, Germany (E.B.R.).

21. Stroke Centre, University of Barcelona, Spain (A.C.).

22. Kreisklinikum Siegen GmbH, Germany (M.G.).

23. University of Marburg, Germany (M.G.).

24. GUIDED Development Heidelberg GmbH, Germany (R. Laage).

25. Lifedatascience Consulting, Schriesheim, Germany (A.S.).

26. Stroke Theme, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Heidelberg, Victoria, Australia (V.T.).

27. Department of Neurology, Austin Health, Heidelberg, Victoria, Australia (V.T.).

Abstract

Background and Purpose: We aimed to investigate fluid-attenuated inversion recovery changes in the penumbra. Methods: We determined core and perfusion lesions in subjects from the WAKE-UP trial (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke) and AXIS 2 trial (Granulocyte Colony-Stimulating Factor in Patients With Acute Ischemic Stroke) with perfusion- and diffusion-weighted imaging at baseline. Only subjects with a mismatch volume >15 mL and ratio >1.2 were included. We created voxel-based relative fluid-attenuated inversion recovery signal intensity (rFLAIR SI) maps at baseline and follow-up. We studied rFLAIR SI in 2 regions of interest: baseline penumbra (baseline perfusion lesion−[core lesion+voxels with apparent diffusion coefficient <620 10 −6 mm 2 /s]) and noninfarcted penumbra (baseline perfusion lesion−follow-up fluid-attenuated inversion recovery lesion) at 24 hours (WAKE-UP) or 30 days (AXIS 2). We analyzed the association between rFLAIR SI and severity of hypoperfusion, defined as time to maximum of the residue function. Results: In the baseline penumbra, rFLAIR SI was elevated (ratio, 1.04; P =1.7×10 13 ; n=126) and correlated with severity of hypoperfusion (Pearson r, 0.03; P <1.0×10 4 ; n=126). In WAKE-UP, imaging at 24 hours revealed a further increase of rFLAIR SI in the noninfarcted penumbra (ratio, 1.05 at 24 hours versus 1.03 at baseline; P =7.1×10 −3 ; n=43). In AXIS 2, imaging at 30 days identified reversibility of the rFLAIR SI (ratio, 1.02 at 30 days versus 1.04 at baseline; P =1.5×10 −3 ; n=26) since it was no longer different from 1 (ratio, 1.01 at 30 days; P =0.099; n=26). Conclusions: Penumbral rFLAIR SI increases appear early after stroke onset, correlate with severity of hypoperfusion, further increase at 24 hours, and are reversible by 30 days. Registration: URL: https://clinicaltrials.gov ; Unique identifier: NCT01525290. URL: https://clinicaltrials.gov ; Unique identifier: NCT00927836.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

Reference32 articles.

1. Molecular pathophysiology of cerebral edema

2. Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke

3. Proton NMR relaxation times in ischemic brain edema.;Horikawa Y;Stroke,1986

4. Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke.;Lansberg MG;AJNR Am J Neuroradiol,2001

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3